home | about us | attorneys | actos | bladder cancer | faqs | articles | law resources | press release | contact us | blog | Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +
New Study Suggests Link between Having Children and Decreased Risk of Bladder Cancer
Posted on January 18th, 2013
No Comments
After studying 2 million+ women, Caroline E. Weibull, MSc and colleagues discovered that there may be a link between bladder cancer and having children. Weibull and colleagues found that women who had children of their own were less likely to develop bladder cancer than women who had never had any children. These researchers also found [...]
Woman accused of faking bladder cancer for personal gain
Posted on October 5th, 2012
No Comments
A New Jersey woman has allegedly faked bladder cancer, scamming friends and relatives out of more than $10,000. She is now being charged with theft by deception. Last February, the woman told her friends and family that she had Stage III bladder cancer and would be beginning chemotherapy and radiation treatment. Two months later, she [...]
First federal Actos trial to be held in 2014
Posted on August 6th, 2012
No Comments
The first federal trial for people who have developed bladder cancer as a result of taking Actos is scheduled for November of 2014. The trial is set to start so far in the future in part due to the sheer number of suits, and in part to give attorneys time to choose the best cases [...]
Bladder cancer clinical trial shows promise
Posted on June 27th, 2012
No Comments
A combination of chemotherapy and radiotherapy have found success in treating advanced bladder cancer during a small clinical trial held at Essex County Hospital in Cholchester, England. Between August 2001 and April 2008, the study examined 35 patients who were suffering from advanced bladder cancer. Doctors found that combining the treatments showed similar results to [...]
Takeda warns doctors of Actos’ bladder cancer risk
Posted on April 25th, 2012
No Comments
Takeda Pharmaceutical, the largest drug manufacturer in Asia, has admitted that its flagship Type 2 diabetes drug, Actos, has a risk of causing bladder cancer. Actos and other pioglitazone-containing drugs can have several serious and potentially fatal side effects. The company wrote a letter to doctors warning them of the risks that are associated with [...]
Review scheduled on Actos lawsuits in Illinois state court
Posted on April 19th, 2012
No Comments
A case management review has been scheduled for April 24 in order to look over the status of the Actos lawsuits in the Illinois State Court. A judge in the Illinois State Court has scheduled the review in order to look into the Actos lawsuits that have been filed at this time. There have been [...]
Cancer-fighting foods
Posted on April 10th, 2012
No Comments
Living a healthy lifestyle and eating a well-balanced diet full of plant food is not only beneficial for your waistline, but it can also help to lower your risk of cancer. Some foods that can help to stop cancer from growing include tomatoes, raw carrots and cruciferous vegetables. Tomatoes include lycopene that help to prevent [...]
Screening tests for bladder cancer
Posted on March 5th, 2012
No Comments
Bladder cancer is the fifth most common cancer that women and men are diagnosed with. Each year, there are 71,000 new cases and 14,000 deaths. Risk factors for bladder cancer include occupational exposure, smoking and being exposed to certain infections from parasites and having a family history of bladder cancer. Also, men have higher diagnosed [...]
Takeda’s new anemia treatment in review by EMA
Posted on March 1st, 2012
No Comments
A new anemia drug developed by Takeda Pharmaceuticals has been accepted for review by the European Medicines Agency. The new drug is designed to be taken once a month for patients with anemia from chronic kidney disease and was discovered by Affymax. If approved by the EMA, Takeda will market the product solely in Europe. [...]
Takeda looking to get TAK-875 to pass in order to replace Actos sales
Posted on February 27th, 2012
No Comments
Takeda Pharmaceutical Co. is currently looking to pass a new drug, TAK-875 and it is in its third and final stage of testing at this time. Takeda is hoping that this new drug will replace the sales from Actos, the Type 2 diabetes medication. In the study done on TAK-875, the drug worked to reduce [...]
By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.
Archives
- May 2013
- April 2013
- February 2013
- January 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
Categories
- Actos and bladder cancer lawyers (17)
- Actos attorneys (12)
- Actos bladder cancer attorneys (9)
- Actos bladder cancer lawsuit attorneys (9)
- Actos bladder cancer lawsuit lawyers (16)
- Actos bladder cancer lawyers (25)
- Actos lawsuit attorneys (26)
- Actos lawsuit lawyers (24)
- Actos lawyers (8)
- Actos mass tort attorneys (2)
- Actos side effects lawyers (3)
- Bladder Cancer and Actos (2)
- bladder cancer symptoms lawyers (4)
- bladder cancer treatments (1)
- Diabetes drug side effect (3)
- Risk of diabetes (1)
- Takeda Pharmaceuticals (4)
- Uncategorized (1)
Blogroll
- Accutane Lawsuit Attorney
- Depakote Lawyers
- Depuy Lawsuit Attorney
- Mesothelioma Lawyers
- Reglan Lawsuit Attorney
- Topamax Lawsuit Attorney